Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07028645

Uroflowmetry and Nocturnal Enuresis

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Enuresis, Nocturnal Behavior Behavioral Symptoms Elimination Disorders Enuresis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Mental Disorders Nocturnal Enuresis Urination Disorders Urogenital Diseases Urologic Diseases

Age range

5 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital

Istanbul, Kadikoy, 34000, Turkey (Türkiye)

About this study

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of enuresis nocturna
  • Patients who have uroflowmetry test

Exclusion criteria

  • Presence of lower urinary tract symptoms
  • Presence of anatomical or neurological problems
  • Patients with missing data

Treatment and study plan

desmopressin melt form 120 μg

Drug

Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.

Desmopressin lyophilisate (Melt)

Drug

Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.

Propiverine tablet

Drug

Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Primary outcomes

  1. Number of days without bedwetting

    Time frame: 1 month

    Achievement of bedwetting in one or less night of a month

Sponsors and collaborators

Lead sponsor

Furkan Adem Canbaz

Other

Registry information

Official study title

Is Uroflowmetry Useful in Assessing Response to Pharmacological Treatment in Enuresis

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Jun 19, 2025
Registry last updated
Jun 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.